612.0K XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 462,414 | 1,750,748 (2%) | 0% | 0 | Common Stock | |
| Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Mar 2025 | 62,382 | 1,688,366 (2%) | 0% | 3.6 | 226,291 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Mar 2025 | 5,030 | 143,502 (0%) | 0% | 3.6 | 18,246 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 52,166 | 148,532 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Mar 2025 | 8,312 | 391,206 (0%) | 0% | 3.6 | 30,152 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 88,148 | 399,518 (0%) | 0% | 0 | Common Stock | |
| Kenneth J. McGrath | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Mar 2025 | 10,673 | 460,987 (0%) | 0% | 3.6 | 38,716 | Common Stock |
| Kenneth J. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 100,647 | 471,660 (0%) | 0% | 0 | Common Stock | |
| Carrie Eglinton Manner | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 28 Feb 2025 | 28,670 | 1,288,334 (2%) | 0% | 3.5 | 100,027 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 27 Feb 2025 | 78,625 | 1,259,664 (2%) | 0% | 3.1 | 247,378 | Common Stock |
| Lelio Marmora | Director | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 27 Feb 2025 | 7,000 | 67,720 (0%) | 0% | 3.1 | 21,420 | Common Stock |
| Kenneth J. McGrath | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 27 Feb 2025 | 64,000 | 371,013 (0%) | 0% | 3.2 | 201,683 | Common Stock |
| Nancy J. Gagliano | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 27 Feb 2025 | 12,750 | 91,524 (0%) | 0% | 3.1 | 39,270 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 01 Feb 2025 | 766 | 96,366 (0%) | 0% | 4.0 | 3,028 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 35,083 | 325,116 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 01 Feb 2025 | 9,945 | 315,171 (0%) | 0% | 4.0 | 39,308 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 01 Feb 2025 | 3,801 | 311,370 (0%) | 0% | 4.0 | 15,023 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.77 per share. | 05 Jan 2025 | 4,822 | 97,132 (0%) | 0% | 3.8 | 18,203 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.78 per share. | 05 Jan 2025 | 6,859 | 290,033 (0%) | 0% | 3.8 | 25,893 | Common Stock |
| Kenneth J. McGrath | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. | 08 Aug 2024 | 19,118 | 307,013 (0%) | 0% | 4.6 | 87,752 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.65 per share. | 04 Jun 2024 | 401,618 | 1,181,039 (1%) | 0% | 4.7 | 1,867,524 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. | 14 May 2024 | 5,364 | 82,146 (0%) | 0% | 5.3 | 28,241 | Common Stock |
| Robert W. McMahon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 19,943 | 42,646 (0%) | 0% | 0 | Common Stock | |
| Mara Glickman Aspinall | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. | 14 May 2024 | 6,619 | 89,716 (0%) | 0% | 5.3 | 34,849 | Common Stock |
| Mara Glickman Aspinall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 24,691 | 114,407 (0%) | 0% | 0 | Common Stock | |
| David J. Shulkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 19,943 | 60,317 (0%) | 0% | 0 | Common Stock | |
| David J. Shulkin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. | 14 May 2024 | 4,964 | 40,374 (0%) | 0% | 5.3 | 26,135 | Common Stock |
| Lelio Marmora | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 19,943 | 60,720 (0%) | 0% | 0 | Common Stock | |
| Lelio Marmora | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. | 14 May 2024 | 3,960 | 40,777 (0%) | 0% | 5.3 | 20,849 | Common Stock |
| Nancy J. Gagliano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 19,943 | 78,774 (0%) | 0% | 0 | Common Stock | |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.22 per share. | 26 Mar 2024 | 871 | 87,510 (0%) | 0% | 6.2 | 5,415 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 6.22 per share. | 26 Mar 2024 | 3,217 | 88,381 (0%) | 0% | 6.2 | 20,002 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 260,688 | 1,612,304 (2%) | 0% | 0 | Common Stock | |
| Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 01 Mar 2024 | 29,647 | 1,582,657 (2%) | 0% | 7.2 | 213,236 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 01 Mar 2024 | 2,708 | 101,954 (0%) | 0% | 7.2 | 19,477 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 24,336 | 104,662 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 41,171 | 301,295 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 01 Mar 2024 | 4,403 | 296,892 (0%) | 0% | 7.2 | 31,669 | Common Stock |
| Kenneth J. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 58,759 | 331,747 (0%) | 0% | 0 | Common Stock | |
| Kenneth J. McGrath | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 01 Mar 2024 | 5,616 | 326,131 (0%) | 0% | 7.2 | 40,393 | Common Stock |
| Kathleen Weber Gallagher | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 23,866 | 271,887 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.39 per share. | 01 Feb 2024 | 11,763 | 260,124 (0%) | 0% | 7.4 | 86,987 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.39 per share. | 01 Feb 2024 | 1,039 | 80,326 (0%) | 0% | 7.4 | 7,683 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 05 Jan 2024 | 4,823 | 81,365 (0%) | 0% | 8.2 | 39,479 | Common Stock |
| Kathleen Weber Gallagher | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 05 Jan 2024 | 6,679 | 248,021 (0%) | 0% | 8.2 | 54,671 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 8.01 per share. | 20 Dec 2023 | 2,498 | 85,840 (0%) | 0% | 8.0 | 19,998 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.01 per share. | 20 Dec 2023 | 676 | 85,164 (0%) | 0% | 8.0 | 5,412 | Common Stock |
| Gallagher Weber Kathleen | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 4,129 | 0 | - | - | Non-Qualified Stock Options | |
| Gallagher Weber Kathleen | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 19 Dec 2023 | 4,129 | 278,829 (0%) | 0% | 5.7 | 23,597 | Common Stock |
| Weber Gallagher Kathleen | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 19 Dec 2023 | 24,129 | 254,700 (0%) | 0% | 8.0 | 194,219 | Common Stock |
| Gagliano J. Nancy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. | 08 Nov 2023 | 3,131 | 58,831 (0%) | 0% | 5.6 | 17,660 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 15 Aug 2023 | 1,758 | 87,946 (0%) | 0% | 5.7 | 10,038 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,758 | 0 | - | - | Non-Qualified Stock Options | |
| Michele Anthony | SVP Finance & CAO | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 15 Aug 2023 | 1,758 | 86,188 (0%) | 0% | 6.5 | 11,427 | Common Stock |
| Kenneth J. McGrath | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.49 per share. | 08 Aug 2023 | 12,524 | 272,988 (0%) | 0% | 6.5 | 81,281 | Common Stock |
| Robert W. McMahon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 22,703 | 22,703 (0%) | 0% | 0 | Common Stock | |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 28 Jun 2023 | 4,004 | 81,566 (0%) | 0% | 5.0 | 20,000 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.00 per share. | 28 Jun 2023 | 1,084 | 80,482 (0%) | 0% | 5.0 | 5,415 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.48 per share. | 04 Jun 2023 | 47,211 | 1,351,616 (2%) | 0% | 5.5 | 258,716 | Common Stock |
| Kenneth J. McGrath | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 30 May 2023 | 100,000 | 285,512 (0%) | 0% | 4.9 | 492,810 | Common Stock |
| Nancy J. Gagliano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 19,802 | 61,962 (0%) | 0% | 0 | Common Stock | |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 19,802 | 77,562 (0%) | 0% | 0 | Common Stock | |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 15 May 2023 | 5,418 | 57,760 (0%) | 0% | 5.6 | 30,422 | Common Stock |
| Anne Michelle Clem Whitaker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.62 per share. | 15 May 2023 | 4,400 | 26,163 (0%) | 0% | 5.6 | 24,706 | Common Stock |
| Anne Michelle Clem Whitaker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.30 per share. | 15 May 2023 | 2,323 | 23,840 (0%) | 0% | 5.3 | 12,318 | Common Stock |
| Mara Glickman Aspinall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 24,517 | 96,335 (0%) | 0% | 0 | Common Stock | |
| Mara Glickman Aspinall | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.62 per share. | 15 May 2023 | 5,400 | 71,818 (0%) | 0% | 5.6 | 30,321 | Common Stock |
| David J. Shulkin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.62 per share. | 15 May 2023 | 5,014 | 25,536 (0%) | 0% | 5.6 | 28,154 | Common Stock |
| David J. Shulkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 19,802 | 45,338 (0%) | 0% | 0 | Common Stock | |
| Lelio Marmora | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.62 per share. | 15 May 2023 | 6,000 | 24,935 (0%) | 0% | 5.6 | 33,690 | Common Stock |
| Lelio Marmora | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 19,802 | 44,737 (0%) | 0% | 0 | Common Stock | |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 04 Apr 2023 | 3,090 | 64,015 (0%) | 0% | 6.5 | 20,000 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.47 per share. | 04 Apr 2023 | 837 | 63,178 (0%) | 0% | 6.5 | 5,417 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 258,065 | 1,398,827 (2%) | 0% | 0 | Common Stock | |
| Michele Anthony | SVP Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 28,367 | 86,188 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 46,371 | 274,700 (0%) | 0% | 0 | Common Stock | |
| Kenneth J. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 53,629 | 185,512 (0%) | 0% | 0 | Common Stock | |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 385 | 58,587 (0%) | 0% | 5.4 | 2,096 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 01 Feb 2023 | 766 | 57,821 (0%) | 0% | 5.4 | 4,171 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 01 Feb 2023 | 853 | 58,972 (0%) | 0% | 5.4 | 4,645 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 1,729 | 231,563 (0%) | 0% | 5.4 | 9,414 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 3,234 | 228,329 (0%) | 0% | 5.4 | 17,609 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 5.45 per share. | 01 Feb 2023 | 13,006 | 240,109 (0%) | 0% | 5.4 | 70,818 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 11,115 | 227,103 (0%) | 0% | 5.4 | 60,521 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 5.44 per share. | 01 Feb 2023 | 39,016 | 238,218 (0%) | 0% | 5.4 | 212,442 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 01 Feb 2023 | 3,705 | 236,404 (0%) | 0% | 5.4 | 20,174 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 01 Feb 2023 | 3,112 | 233,292 (0%) | 0% | 5.4 | 16,945 | Common Stock |
| Michele Anthony | SVP Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 05 Jan 2023 | 4,800 | 59,825 (0%) | 0% | 4.9 | 23,400 | Common Stock |
| Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 05 Jan 2023 | 6,857 | 199,202 (0%) | 0% | 4.9 | 33,428 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 4.91 per share. | 20 Dec 2022 | 3,752 | 61,941 (0%) | 0% | 4.9 | 18,441 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.92 per share. | 20 Dec 2022 | 1,016 | 60,925 (0%) | 0% | 4.9 | 4,994 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.96 per share. | 05 Oct 2022 | 1,110 | 58,189 (0%) | 0% | 4.0 | 4,401 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 3.97 per share. | 05 Oct 2022 | 4,098 | 59,299 (0%) | 0% | 4.0 | 16,249 | Common Stock |
| Ronny B. Lancaster | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 26 Aug 2022 | 50,000 | 104,782 (0%) | 0% | 4 | 200,000 | Common Stock |
| Mara Glickman Aspinall | Director | Purchase of securities on an exchange or from another person at price $ 4.19 per share. | 25 Aug 2022 | 6,000 | 77,218 (0%) | 0% | 4.2 | 25,138 | Common Stock |
| Nancy J. Gagliano | Director | Purchase of securities on an exchange or from another person at price $ 4.39 per share. | 17 Aug 2022 | 2,200 | 42,160 (0%) | 0% | 4.4 | 9,658 | Common Stock |
| Michael Celano | Director | Purchase of securities on an exchange or from another person at price $ 4.49 per share. | 12 Aug 2022 | 12,000 | 111,823 (0%) | 0% | 4.5 | 53,916 | Common Stock |
| Ken McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.03 per share. | 08 Aug 2022 | 131,883 | 131,883 (0%) | 0% | 3.0 | 400,001 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 27 Jun 2022 | 1,523 | 55,201 (0%) | 0% | 2.9 | 4,402 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 2.89 per share. | 27 Jun 2022 | 5,623 | 56,724 (0%) | 0% | 2.9 | 16,251 | Common Stock |
| Nancy J. Gagliano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.25 per share. | 16 Jun 2022 | 1,939 | 41,899 (0%) | 0% | 4.3 | 8,250 | Common Stock |
| Nancy J. Gagliano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.62 per share. | 16 Jun 2022 | 1,939 | 39,960 (0%) | 0% | 3.6 | 7,019 | Common Stock |
| Nancy J. Gagliano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.21 per share. | 16 Jun 2022 | 1,963 | 43,838 (0%) | 0% | 6.2 | 12,195 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 4.91 per share. | 04 Jun 2022 | 325,932 | 1,140,762 (1%) | 0% | 4.9 | 1,600,000 | Common Stock |
| Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 4.91 per share. | 04 Jun 2022 | 814,830 | 814,830 (1%) | 1% | 4.9 | 4,000,000 | Common Stock |
| Mara Glickman Aspinall | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 03 Jun 2022 | 24,983 | 77,963 (0%) | 0% | 4.0 | 99,999 | Common Stock |
| Mara Glickman Aspinall | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 03 Jun 2022 | 6,745 | 71,218 (0%) | 0% | 4.0 | 26,998 | Common Stock |
| Lelio Marmora | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.12 per share. | 01 Jun 2022 | 2,104 | 30,935 (0%) | 0% | 4.1 | 8,679 | Common Stock |
| Scott Gleason | Interim CFO/SVP IR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 21 May 2022 | 1,996 | 96,509 (0%) | 0% | 5.5 | 11,038 | Common Stock |
| Eamonn P. Hobbs | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.25 per share. | 16 May 2022 | 2,409 | 41,452 (0%) | 0% | 5.2 | 12,647 | Common Stock |
| Eamonn P. Hobbs | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 61,452 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 51,101 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| Ronny B. Lancaster | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 54,782 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| Michael Celano | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 24,762 | 99,823 (0%) | 0% | 5.3 | 130,001 | Common Stock |
| Michael Celano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.25 per share. | 16 May 2022 | 3,399 | 75,061 (0%) | 0% | 5.3 | 17,845 | Common Stock |
| Anne Michelle Clem Whitaker | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 30,563 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| Mara Glickman Aspinall | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.25 per share. | 16 May 2022 | 2,957 | 32,980 (0%) | 0% | 5.2 | 15,524 | Common Stock |
| Mara Glickman Aspinall | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 52,980 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| David J. Shulkin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.25 per share. | 16 May 2022 | 2,745 | 10,550 (0%) | 0% | 5.2 | 14,411 | Common Stock |
| David J. Shulkin | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 30,550 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| Lelio Marmora | Director | Grant, award, or other acquisition of securities at price $ 5.25 per share. | 16 May 2022 | 20,000 | 33,039 (0%) | 0% | 5.3 | 105,000 | Common Stock |
| Lelio Marmora | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.25 per share. | 16 May 2022 | 4,928 | 13,039 (0%) | 0% | 5.3 | 25,872 | Common Stock |
| Lisa Nibauer | President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.05 per share. | 11 May 2022 | 1,606 | 123,479 (0%) | 0% | 5.1 | 8,118 | Common Stock |
| David J. Shulkin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. | 06 Apr 2022 | 2,247 | 13,295 (0%) | 0% | 6.7 | 15,077 | Common Stock |
| Nancy J. Gagliano | Director, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 99,259 | 120,245 (0%) | 0% | 0 | Common Stock | |
| Nancy J. Gagliano | Director, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 14,815 | 25,378 (0%) | 0% | 0 | Common Stock | |
| Nancy J. Gagliano | Director, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.75 per share. | 01 Apr 2022 | 4,392 | 20,986 (0%) | 0% | 6.8 | 29,646 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 6.92 per share. | 25 Mar 2022 | 2,349 | 31,737 (0%) | 0% | 6.9 | 16,249 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.92 per share. | 25 Mar 2022 | 636 | 31,101 (0%) | 0% | 6.9 | 4,400 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 4,544 | 255,657 (0%) | 0% | 8.9 | 40,260 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 10,225 | 349,793 (0%) | 0% | 8.9 | 90,594 | Common Stock |
| Stephen S. Tang | President and CEO | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 25,679 | 360,018 (0%) | 0% | 8.9 | 227,516 | Common Stock |
| Stephen S. Tang | President and CEO | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 94,234 | 334,339 (0%) | 0% | 8.9 | 834,913 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 6,962 | 240,105 (0%) | 0% | 8.9 | 61,683 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 8,590 | 247,067 (0%) | 0% | 8.9 | 76,107 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 849 | 58,237 (0%) | 0% | 8.9 | 7,522 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 384 | 57,853 (0%) | 0% | 8.9 | 3,402 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 6,772 | 64,625 (0%) | 0% | 8.9 | 60,000 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 21,687 | 96,854 | - | - | Option (right to buy) | |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 429 | 59,086 (0%) | 0% | 8.9 | 3,801 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 2,782 | 206,059 (0%) | 0% | 8.9 | 24,649 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 6,989 | 208,841 (0%) | 0% | 8.9 | 61,923 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 34,061 | 201,852 (0%) | 0% | 8.9 | 301,780 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 1,685 | 167,791 (0%) | 0% | 8.9 | 14,929 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 3,592 | 169,476 (0%) | 0% | 8.9 | 31,825 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 1,467 | 173,068 (0%) | 0% | 8.9 | 12,998 | Common Stock |
| Lisa Nibauer | President-Diagnostics | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 34,556 | 125,085 (0%) | 0% | 8.9 | 306,166 | Common Stock |
| Lisa Nibauer | President-Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 2,606 | 90,529 (0%) | 0% | 8.9 | 23,089 | Common Stock |
| Scott Gleason | Interim CFO/SVP IR | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 29,345 | 98,505 (0%) | 0% | 8.9 | 259,997 | Common Stock |
| Agnieszka M. Gallagher | General Counsel CCO | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 38,050 | 90,584 (0%) | 0% | 8.9 | 337,123 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 05 Jan 2022 | 42,631 | 59,515 (0%) | 0% | 8.2 | 350,001 | Common Stock |
| Kathleen Gallagher Weber | President - Molecular Sol | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 05 Jan 2022 | 60,901 | 174,535 (0%) | 0% | 8.2 | 499,997 | Common Stock |
| Lisa Nibauer | President-Diagnostics | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 05 Jan 2022 | 60,901 | 93,135 (0%) | 0% | 8.2 | 499,997 | Common Stock |
| Scott Gleason | Interim CFO/SVP IR | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 05 Jan 2022 | 48,721 | 69,160 (0%) | 0% | 8.2 | 399,999 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 9.46 per share. | 22 Dec 2021 | 1,717 | 29,388 (0%) | 0% | 9.5 | 16,251 | Common Stock |
| Agnieszka M. Gallagher | General Counsel CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2021 | 113,448 | 113,448 | - | - | Option (right to buy) | |
| Agnieszka M. Gallagher | General Counsel CCO | Grant, award, or other acquisition of securities at price $ 9.52 per share. | 29 Nov 2021 | 26,267 | 52,534 (0%) | 0% | 9.5 | 249,996 | Common Stock |
| Agnieszka M. Gallagher | General Counsel CCO | Grant, award, or other acquisition of securities at price $ 9.52 per share. | 29 Nov 2021 | 26,267 | 26,267 (0%) | 0% | 9.5 | 249,996 | Common Stock |
| Anne Michelle Clem Whitaker | Director | Grant, award, or other acquisition of securities at price $ 9.94 per share. | 08 Nov 2021 | 10,563 | 10,563 (0%) | 0% | 9.9 | 104,996 | Common Stock |
| Nancy J. Gagliano | Director | Grant, award, or other acquisition of securities at price $ 9.94 per share. | 08 Nov 2021 | 10,563 | 10,563 (0%) | 0% | 9.9 | 104,996 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 11.58 per share. | 30 Sep 2021 | 1,404 | 27,671 (0%) | 0% | 11.6 | 16,258 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.15 per share. | 12 Aug 2021 | 3,673 | 26,802 (0%) | 0% | 11.2 | 40,954 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 10.23 per share. | 30 Jun 2021 | 1,589 | 30,475 (0%) | 0% | 10.2 | 16,255 | Common Stock |
| Ronny B. Lancaster | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 18 May 2021 | 10,952 | 34,782 (0%) | 0% | 9.6 | 105,002 | Common Stock |
| Lelio Marmora | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 18 May 2021 | 10,952 | 17,967 (0%) | 0% | 9.6 | 105,002 | Common Stock |
| Eamonn P. Hobbs | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.50 per share. | 17 May 2021 | 1,446 | 32,909 (0%) | 0% | 9.5 | 13,739 | Common Stock |
| Eamonn P. Hobbs | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 17 May 2021 | 10,952 | 43,861 (0%) | 0% | 9.6 | 105,002 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.50 per share. | 17 May 2021 | 1,798 | 17,934 (0%) | 0% | 9.5 | 17,083 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 17 May 2021 | 10,952 | 28,886 (0%) | 0% | 9.6 | 105,002 | Common Stock |
| Michael Celano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.50 per share. | 17 May 2021 | 2,041 | 64,901 (0%) | 0% | 9.5 | 19,392 | Common Stock |
| Michael Celano | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 17 May 2021 | 13,559 | 78,460 (0%) | 0% | 9.6 | 129,997 | Common Stock |
| Mara Glickman Aspinall | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 17 May 2021 | 10,952 | 35,937 (0%) | 0% | 9.6 | 105,002 | Common Stock |
| Mara Glickman Aspinall | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.50 per share. | 17 May 2021 | 1,775 | 24,985 (0%) | 0% | 9.5 | 16,865 | Common Stock |
| David J. Shulkin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.50 per share. | 17 May 2021 | 1,648 | 13,894 (0%) | 0% | 9.5 | 15,658 | Common Stock |
| David J. Shulkin | Director | Grant, award, or other acquisition of securities at price $ 9.59 per share. | 17 May 2021 | 10,952 | 24,846 (0%) | 0% | 9.6 | 105,002 | Common Stock |
| Lisa Nibauer | EVP BU Lead-Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.55 per share. | 11 May 2021 | 1,606 | 32,234 (0%) | 0% | 9.5 | 15,337 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 07 May 2021 | 1,359 | 107,479 (0%) | 0% | 9.8 | 13,386 | Common Stock |
| Roberto Cuca | CFO | Grant, award, or other acquisition of securities at price $ 9.85 per share. | 07 May 2021 | 10,740 | 118,219 (0%) | 0% | 9.9 | 105,789 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 07 May 2021 | 3,404 | 114,815 (0%) | 0% | 9.8 | 33,529 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 11.60 per share. | 31 Mar 2021 | 1,401 | 19,732 (0%) | 0% | 11.6 | 16,252 | Common Stock |
| Jack E. Jerrett | SVP General Counsel CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 2,723 | 144,875 (0%) | 0% | 15.6 | 42,356 | Common Stock |
| Jack E. Jerrett | SVP General Counsel CCO | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 6,567 | 147,598 (0%) | 0% | 15.6 | 102,149 | Common Stock |
| Jack E. Jerrett | SVP General Counsel CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 2,824 | 129,293 (0%) | 0% | 15.6 | 43,927 | Common Stock |
| Jack E. Jerrett | SVP General Counsel CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 4,951 | 124,342 (0%) | 0% | 15.6 | 77,012 | Common Stock |
| Jack E. Jerrett | SVP General Counsel CCO | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 16,689 | 141,031 (0%) | 0% | 15.6 | 259,596 | Common Stock |
| Jack E. Jerrett | SVP General Counsel CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 1,391 | 132,117 (0%) | 0% | 15.6 | 21,637 | Common Stock |
| Stephen S. Tang | President and CEO | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 73,342 | 260,201 (0%) | 0% | 15.6 | 1,140,827 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 8,068 | 186,859 (0%) | 0% | 15.6 | 125,497 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 4,836 | 194,927 (0%) | 0% | 15.6 | 75,223 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 2,696 | 88,657 (0%) | 0% | 15.6 | 41,936 | Common Stock |
| Roberto Cuca | CFO | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 24,706 | 108,838 (0%) | 0% | 15.6 | 384,299 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 4,525 | 84,132 (0%) | 0% | 15.6 | 70,386 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 109 | 14,752 (0%) | 0% | 15.6 | 1,695 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 429 | 14,323 (0%) | 0% | 15.6 | 6,673 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 849 | 13,474 (0%) | 0% | 15.6 | 13,206 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 3,410 | 16,884 (0%) | 0% | 15.6 | 53,042 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 11,505 | 75,167 | - | - | Option (right to buy) | |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 6,006 | 115,344 (0%) | 0% | 15.6 | 93,423 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 1,710 | 113,634 (0%) | 0% | 15.6 | 26,599 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 3,057 | 91,120 (0%) | 0% | 15.6 | 47,551 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 1,466 | 94,177 (0%) | 0% | 15.6 | 22,803 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 901 | 95,643 (0%) | 0% | 15.6 | 14,015 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 18,218 | 109,338 (0%) | 0% | 15.6 | 283,379 | Common Stock |
| Lisa Nibauer | EVP BU Lead-Diagnostics | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 19,769 | 33,840 (0%) | 0% | 15.6 | 307,505 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.32 per share. | 18 Dec 2020 | 392 | 18,331 (0%) | 0% | 11.3 | 4,437 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 11.32 per share. | 18 Dec 2020 | 1,436 | 18,723 (0%) | 0% | 11.3 | 16,256 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 10.89 per share. | 25 Sep 2020 | 1,492 | 17,695 (0%) | 0% | 10.9 | 16,248 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.89 per share. | 25 Sep 2020 | 408 | 17,287 (0%) | 0% | 10.9 | 4,443 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 9.74 per share. | 23 Jun 2020 | 1,667 | 16,658 (0%) | 0% | 9.7 | 16,244 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.75 per share. | 23 Jun 2020 | 455 | 16,203 (0%) | 0% | 9.7 | 4,434 | Common Stock |
| Lelio Marmora | Director | Grant, award, or other acquisition of securities at price $ 14.26 per share. | 01 Jun 2020 | 7,015 | 7,015 (0%) | 0% | 14.3 | 99,999 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 15.97 per share. | 18 May 2020 | 6,577 | 21,568 (0%) | 0% | 16.0 | 105,002 | Common Stock |
| David Shulkin | Director | Grant, award, or other acquisition of securities at price $ 15.97 per share. | 18 May 2020 | 6,577 | 15,542 (0%) | 0% | 16.0 | 105,002 | Common Stock |
| Eamonn P. Hobbs | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.04 per share. | 15 May 2020 | 2,724 | 27,778 (0%) | 0% | 16.0 | 43,693 | Common Stock |
| Eamonn P. Hobbs | Director | Grant, award, or other acquisition of securities at price $ 15.97 per share. | 15 May 2020 | 6,577 | 34,355 (0%) | 0% | 16.0 | 105,002 | Common Stock |
| Ronny B. Lancaster | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.04 per share. | 15 May 2020 | 3,776 | 17,253 (0%) | 0% | 16.0 | 60,567 | Common Stock |
| Ronny B. Lancaster | Director | Grant, award, or other acquisition of securities at price $ 15.97 per share. | 15 May 2020 | 6,577 | 23,830 (0%) | 0% | 16.0 | 105,002 | Common Stock |
| Charles W. Patrick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.04 per share. | 15 May 2020 | 3,990 | 58,446 (0%) | 0% | 16.0 | 64,000 | Common Stock |
| Michael Celano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.04 per share. | 15 May 2020 | 3,843 | 58,799 (0%) | 0% | 16.0 | 61,642 | Common Stock |
| Michael Celano | Director | Grant, award, or other acquisition of securities at price $ 15.97 per share. | 15 May 2020 | 8,143 | 66,942 (0%) | 0% | 16.0 | 130,003 | Common Stock |
| Mara Glickman Aspinall | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.04 per share. | 15 May 2020 | 3,343 | 20,183 (0%) | 0% | 16.0 | 53,622 | Common Stock |
| Mara Glickman Aspinall | Director | Grant, award, or other acquisition of securities at price $ 15.97 per share. | 15 May 2020 | 6,577 | 26,760 (0%) | 0% | 16.0 | 105,002 | Common Stock |
| Lisa Nibauer | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 17.77 per share. | 11 May 2020 | 14,071 | 14,071 (0%) | 0% | 17.8 | 250,006 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.09 per share. | 07 May 2020 | 1,359 | 91,353 (0%) | 0% | 16.1 | 21,873 | Common Stock |
| James A. Datin | Director | Grant, award, or other acquisition of securities at price $ 10.61 per share. | 08 Apr 2020 | 2,145 | 15,577 (0%) | 0% | 10.6 | 22,748 | Common Stock |
| James A. Datin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.61 per share. | 08 Apr 2020 | 586 | 14,991 (0%) | 0% | 10.6 | 6,215 | Common Stock |
| David Shulkin | Director | Grant, award, or other acquisition of securities at price $ 11.16 per share. | 06 Apr 2020 | 8,965 | 8,965 (0%) | 0% | 11.2 | 100,005 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 4,850 | 127,180 (0%) | 0% | 7.2 | 34,750 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 2,426 | 89,459 (0%) | 0% | 7.2 | 17,382 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 1,423 | 88,036 (0%) | 0% | 7.2 | 10,196 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 3,012 | 85,024 (0%) | 0% | 7.2 | 21,581 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 35,813 | 120,837 (0%) | 0% | 7.2 | 256,600 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 01 Feb 2020 | 11,193 | 132,030 (0%) | 0% | 7.2 | 80,198 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 11,195 | 138,375 (0%) | 0% | 7.2 | 80,212 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 4,867 | 133,508 (0%) | 0% | 7.2 | 34,872 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 16,560 | 235,398 (0%) | 0% | 7.2 | 118,652 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 7,531 | 227,867 (0%) | 0% | 7.2 | 53,960 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 3,736 | 179,874 (0%) | 0% | 7.2 | 26,768 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 1,644 | 178,230 (0%) | 0% | 7.2 | 11,779 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 3,175 | 175,055 (0%) | 0% | 7.2 | 22,749 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 34,698 | 209,753 (0%) | 0% | 7.2 | 248,611 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 16,560 | 226,313 (0%) | 0% | 7.2 | 118,652 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 7,475 | 218,838 (0%) | 0% | 7.2 | 53,558 | Common Stock |
| Stephen S. Tang | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 5,194 | 114,766 (0%) | 0% | 7.2 | 37,215 | Common Stock |
| Stephen S. Tang | President and CEO | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 01 Feb 2020 | 84,997 | 199,763 (0%) | 0% | 7.2 | 609,004 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 2,771 | 44,804 (0%) | 0% | 7.2 | 19,854 | Common Stock |
| Roberto Cuca | CFO | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 01 Feb 2020 | 47,908 | 92,712 (0%) | 0% | 7.2 | 343,261 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 429 | 7,316 (0%) | 0% | 7.2 | 3,074 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 217 | 7,854 (0%) | 0% | 7.2 | 1,555 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2020 | 29,071 | 63,662 | - | - | Option (right to buy) | |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 01 Feb 2020 | 7,545 | 14,861 (0%) | 0% | 7.2 | 54,060 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 109 | 7,745 (0%) | 0% | 7.2 | 781 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 1,536 | 61,843 (0%) | 0% | 7.2 | 11,005 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 901 | 60,942 (0%) | 0% | 7.2 | 6,456 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 2,900 | 106,544 (0%) | 0% | 7.2 | 20,779 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 10,238 | 109,444 (0%) | 0% | 7.2 | 73,355 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.17 per share. | 01 Feb 2020 | 3,023 | 99,206 (0%) | 0% | 7.2 | 21,660 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 10,238 | 102,229 (0%) | 0% | 7.2 | 73,355 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 7.16 per share. | 01 Feb 2020 | 32,516 | 91,991 (0%) | 0% | 7.2 | 232,977 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 01 Feb 2020 | 1,467 | 59,475 (0%) | 0% | 7.2 | 10,511 | Common Stock |
| James A. Datin | None | Grant, award, or other acquisition of securities at price $ 7.44 per share. | 12 Aug 2019 | 13,432 | 13,432 (0%) | 0% | 7.4 | 100,001 | Common Stock |
| Eamonn P. Hobbs | None | Grant, award, or other acquisition of securities at price $ 8.48 per share. | 21 May 2019 | 12,382 | 30,502 (0%) | 0% | 8.5 | 104,999 | Common Stock |
| Ronny B. Lancaster | None | Grant, award, or other acquisition of securities at price $ 8.48 per share. | 21 May 2019 | 12,382 | 21,029 (0%) | 0% | 8.5 | 104,999 | Common Stock |
| Charles W. Patrick | None | Grant, award, or other acquisition of securities at price $ 8.48 per share. | 21 May 2019 | 12,382 | 62,436 (0%) | 0% | 8.5 | 104,999 | Common Stock |
| Michael Celano | None | Grant, award, or other acquisition of securities at price $ 8.48 per share. | 21 May 2019 | 15,330 | 62,642 (0%) | 0% | 8.5 | 129,998 | Common Stock |
| Mara Glickman Aspinall | None | Grant, award, or other acquisition of securities at price $ 8.48 per share. | 21 May 2019 | 12,382 | 23,526 (0%) | 0% | 8.5 | 104,999 | Common Stock |
| Aradhana Sarin | None | Grant, award, or other acquisition of securities at price $ 8.48 per share. | 21 May 2019 | 12,382 | 16,865 (0%) | 0% | 8.5 | 104,999 | Common Stock |
| Stephen S. Tang | President and CEO | Purchase of securities on an exchange or from another person at price $ 8.56 per share. | 14 May 2019 | 1,000 | 119,960 (0%) | 0% | 8.6 | 8,560 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 13 May 2019 | 8,687 | 91,885 (0%) | 0% | 8.6 | 74,274 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Purchase of securities on an exchange or from another person at price $ 8.54 per share. | 13 May 2019 | 1,313 | 83,198 (0%) | 0% | 8.5 | 11,213 | Common Stock |
| Roberto Cuca | CFO | Purchase of securities on an exchange or from another person at price $ 9.01 per share. | 10 May 2019 | 1,300 | 45,268 (0%) | 0% | 9.0 | 11,713 | Common Stock |
| Roberto Cuca | CFO | Purchase of securities on an exchange or from another person at price $ 9.00 per share. | 10 May 2019 | 407 | 47,575 (0%) | 0% | 9 | 3,663 | Common Stock |
| Roberto Cuca | CFO | Purchase of securities on an exchange or from another person at price $ 9.03 per share. | 10 May 2019 | 700 | 47,168 (0%) | 0% | 9.0 | 6,321 | Common Stock |
| Roberto Cuca | CFO | Purchase of securities on an exchange or from another person at price $ 9.02 per share. | 10 May 2019 | 1,200 | 46,468 (0%) | 0% | 9.0 | 10,824 | Common Stock |
| Roberto Cuca | CFO | Purchase of securities on an exchange or from another person at price $ 9.04 per share. | 10 May 2019 | 6,393 | 43,968 (0%) | 0% | 9.0 | 57,793 | Common Stock |
| Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.84 per share. | 07 May 2019 | 1,359 | 37,575 (0%) | 0% | 9.8 | 13,373 | Common Stock |
| Eamonn P. Hobbs | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 06 May 2019 | 1,351 | 18,120 (0%) | 0% | 9.9 | 13,351 | Common Stock |
| Ronny B. Lancaster | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 06 May 2019 | 1,873 | 8,647 (0%) | 0% | 9.9 | 18,510 | Common Stock |
| Charles W. Patrick | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 06 May 2019 | 1,980 | 50,054 (0%) | 0% | 9.9 | 19,567 | Common Stock |
| Aradhana Sarin | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 06 May 2019 | 1,661 | 4,483 (0%) | 0% | 9.9 | 16,415 | Common Stock |
| Michael Reed | SVP RD and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.55 per share. | 18 Apr 2019 | 2,674 | 49,217 (0%) | 0% | 9.6 | 25,537 | Common Stock |
| Stephen S. Tang | President and CEO | Sale of securities on an exchange or to another person at price $ 11.10 per share. | 01 Apr 2019 | 16,667 | 118,960 (0%) | 0% | 11.1 | 185,015 | Common Stock |
| Stephen S. Tang | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2019 | 16,667 | 0 | - | - | Option (right to buy) | |
| Stephen S. Tang | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.33 per share. | 01 Apr 2019 | 16,667 | 135,627 (0%) | 0% | 8.3 | 138,753 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 7,842 | 71,689 (0%) | 0% | 13.0 | 101,809 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 18,038 | 89,727 (0%) | 0% | 13.0 | 234,178 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 7,842 | 81,885 (0%) | 0% | 13.0 | 101,809 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 1,266 | 42,969 (0%) | 0% | 13.0 | 16,436 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 2,123 | 44,235 (0%) | 0% | 13.0 | 27,562 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 3,910 | 46,358 (0%) | 0% | 13.0 | 50,762 | Common Stock |
| Jack E. Jerrett | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 18,524 | 61,493 (0%) | 0% | 0 | Common Stock | |
| Jack E. Jerrett | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 18,038 | 79,531 (0%) | 0% | 13.0 | 234,178 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 24,135 | 194,827 (0%) | 0% | 13.0 | 313,333 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 5,371 | 143,012 (0%) | 0% | 13.0 | 69,729 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 3,400 | 139,612 (0%) | 0% | 13.0 | 44,141 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 1,505 | 138,107 (0%) | 0% | 13.0 | 19,539 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 19,667 | 157,774 (0%) | 0% | 0 | Common Stock | |
| Anthony Zezzo | EVP BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 24,135 | 181,909 (0%) | 0% | 13.0 | 313,333 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 11,217 | 170,692 (0%) | 0% | 13.0 | 145,625 | Common Stock |
| Anthony Zezzo | EVP BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 11,217 | 183,610 (0%) | 0% | 13.0 | 145,625 | Common Stock |
| Stephen S. Tang | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 47,872 | 118,960 (0%) | 0% | 0 | Common Stock | |
| Roberto Cuca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 24,614 | 38,934 (0%) | 0% | 0 | Common Stock | |
| Michael Reed | SVP RD and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 1,881 | 28,204 (0%) | 0% | 13.0 | 24,420 | Common Stock |
| Michael Reed | SVP RD and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 524 | 27,680 (0%) | 0% | 13.0 | 6,803 | Common Stock |
| Michael Reed | SVP RD and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 6,470 | 34,150 (0%) | 0% | 0 | Common Stock | |
| Michael Reed | SVP RD and CSO | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 14,510 | 48,660 (0%) | 0% | 13.0 | 188,376 | Common Stock |
| Michael Reed | SVP RD and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 5,694 | 51,891 (0%) | 0% | 13.0 | 73,922 | Common Stock |
| Michael Reed | SVP RD and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 5,583 | 43,077 (0%) | 0% | 13.0 | 72,481 | Common Stock |
| Michael Reed | SVP RD and CSO | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 14,508 | 57,585 (0%) | 0% | 13.0 | 188,350 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 217 | 4,367 (0%) | 0% | 13.0 | 2,817 | Common Stock |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 381 | 4,584 (0%) | 0% | 13.0 | 4,946 | Common Stock |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 13,986 | 34,591 | - | - | Option (right to buy) | |
| Michele Miller | VP, Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 3,813 | 8,071 (0%) | 0% | 0 | Common Stock | |
| Michele Miller | VP, Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 109 | 4,258 (0%) | 0% | 13.0 | 1,415 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 13,028 | 34,197 (0%) | 0% | 0 | Common Stock | |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 20,400 | 54,597 (0%) | 0% | 13.0 | 264,843 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 5,809 | 48,788 (0%) | 0% | 13.0 | 75,415 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 5,809 | 63,379 (0%) | 0% | 13.0 | 75,415 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 12.98 per share. | 01 Feb 2019 | 20,400 | 69,188 (0%) | 0% | 13.0 | 264,843 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 2,985 | 23,189 (0%) | 0% | 13.0 | 38,753 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 1,260 | 21,929 (0%) | 0% | 13.0 | 16,358 | Common Stock |
| Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 01 Feb 2019 | 760 | 21,169 (0%) | 0% | 13.0 | 9,867 | Common Stock |
| Charles W. Patrick | None | Gift of securities by or to the insider at price $ 13.25 per share. | 28 Nov 2018 | 2,264 | 52,034 (0%) | 0% | 13.3 | 29,998 | Common Stock |
| Mark L. Kuna | See Remarks | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 22 Oct 2018 | 8,777 | 70,043 (0%) | 0% | 14.8 | 129,987 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 2,907 | 46,306 (0%) | 0% | 14.8 | 43,053 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 2,543 | 43,763 (0%) | 0% | 14.8 | 37,662 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 1,989 | 41,774 (0%) | 0% | 14.8 | 29,457 | Common Stock |
| Mark L. Kuna | See Remarks | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 22 Oct 2018 | 15,048 | 56,822 (0%) | 0% | 14.8 | 222,861 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 6,542 | 50,280 (0%) | 0% | 14.8 | 96,887 | Common Stock |
| Mark L. Kuna | See Remarks | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 22 Oct 2018 | 15,047 | 65,327 (0%) | 0% | 14.8 | 222,846 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 6,542 | 58,785 (0%) | 0% | 14.8 | 96,887 | Common Stock |
| Mark L. Kuna | See Remarks | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 22 Oct 2018 | 4,388 | 63,173 (0%) | 0% | 14.8 | 64,986 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 1,907 | 61,266 (0%) | 0% | 14.8 | 28,243 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 3,816 | 66,227 (0%) | 0% | 14.8 | 56,515 | Common Stock |
| Mark L. Kuna | See Remarks | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 22 Oct 2018 | 1,716 | 67,943 (0%) | 0% | 14.8 | 25,414 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 746 | 67,197 (0%) | 0% | 14.8 | 11,048 | Common Stock |
| Mark L. Kuna | See Remarks | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 22 Oct 2018 | 1,716 | 68,913 (0%) | 0% | 14.8 | 25,414 | Common Stock |
| Mark L. Kuna | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.81 per share. | 22 Oct 2018 | 746 | 68,167 (0%) | 0% | 14.8 | 11,048 | Common Stock |
| Charles W. Patrick | None | Sale of securities on an exchange or to another person at price $ 16.29 per share. | 27 Aug 2018 | 8,000 | 54,298 (0%) | 0% | 16.3 | 130,320 | Common Stock |
| Ronald H. Spair | Director, COO & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.39 per share. | 08 Jun 2018 | 1,545 | 164,857 (0%) | 0% | 17.4 | 26,875 | Common stock |
| Eamonn P. Hobbs | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.97 per share. | 14 May 2018 | 1,384 | 19,471 (0%) | 0% | 16.0 | 22,109 | Common stock |
| Ronny B. Lancaster | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.97 per share. | 14 May 2018 | 1,919 | 10,520 (0%) | 0% | 16.0 | 30,656 | Common stock |
| Charles W. Patrick | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.97 per share. | 14 May 2018 | 2,028 | 62,298 (0%) | 0% | 16.0 | 32,397 | Common stock |
| Michael Celano | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.98 per share. | 14 May 2018 | 1,578 | 47,312 (0%) | 0% | 16.0 | 25,209 | Common stock |
| Stephen S. Tang | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.98 per share. | 14 May 2018 | 2,444 | 71,088 (0%) | 0% | 16.0 | 39,043 | Common stock |
| Eamonn P. Hobbs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2018 | 6,144 | 20,855 (0%) | 0% | 0 | Common stock | |
| Ronny B. Lancaster | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2018 | 6,144 | 12,439 (0%) | 0% | 0 | Common stock | |
| Charles W. Patrick | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2018 | 6,144 | 64,326 (0%) | 0% | 0 | Common stock | |
| Michael Celano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2018 | 7,762 | 48,890 (0%) | 0% | 0 | Common stock | |
| Mara Glickman Aspinall | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2018 | 6,144 | 11,144 (0%) | 0% | 0 | Common stock | |
| Aradhana Sarin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2018 | 6,144 | 6,144 (0%) | 0% | 0 | Common stock | |
| Michael Reed | SVP R&D and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.77 per share. | 18 Apr 2018 | 1,836 | 30,085 (0%) | 0% | 17.8 | 32,617 | Common stock |
| Michael Celano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2018 | 40,000 | 40,000 | - | - | Nonqualified stock options | |
| Stephen S. Tang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2018 | 37,116 | 73,532 (0%) | 0% | 0 | Common stock | |
| Douglas A. Michels | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.79 per share. | 31 Mar 2018 | 56,078 | 660,861 (1%) | 0% | 16.8 | 941,830 | Common stock |
| Stephen S. Tang | None | Sale of securities on an exchange or to another person at price $ 17.97 per share. | 15 Feb 2018 | 23,333 | 36,416 (0%) | 0% | 18.0 | 419,247 | Common stock |
| Stephen S. Tang | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 23,333 | 16,667 | - | - | Nonqualified stock options | |
| Stephen S. Tang | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 15 Feb 2018 | 23,333 | 59,749 (0%) | 0% | 8.3 | 194,247 | Common stock |
| Brian Smith | EVP & BU Lead - Molecular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 10,000 | 10,000 | - | - | Nonqualified stock options | |
| Brian Smith | EVP & BU Lead - Molecular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 10,000 | 0 | - | - | Nonqualified stock options | |
| Brian Smith | EVP & BU Lead - Molecular | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 15 Feb 2018 | 10,000 | 18,075 (0%) | 0% | 18.0 | 180,010 | Common stock |
| Brian Smith | EVP & BU Lead - Molecular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.96 per share. | 15 Feb 2018 | 10,000 | 28,075 (0%) | 0% | 6.0 | 59,590 | Common stock |
| Brian Smith | EVP & BU Lead - Molecular | Sale of securities on an exchange or to another person at price $ 17.94 per share. | 15 Feb 2018 | 10,000 | 18,075 (0%) | 0% | 17.9 | 179,450 | Common stock |
| Brian Smith | EVP & BU Lead - Molecular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.96 per share. | 15 Feb 2018 | 10,000 | 28,075 (0%) | 0% | 6.0 | 59,590 | Common stock |
| Douglas A. Michels | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.64 per share. | 01 Feb 2018 | 27,985 | 689,060 (1%) | 0% | 21.6 | 605,735 | Common stock |
| Douglas A. Michels | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 36,615 | 725,675 (1%) | 0% | 0 | Common stock | |
| Douglas A. Michels | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 01 Feb 2018 | 8,736 | 716,939 (1%) | 0% | 21 | 183,456 | Common stock |
| Douglas A. Michels | Director, President & CEO | Gift of securities by or to the insider at price $ 19.39 per share. | 01 Feb 2018 | 3,090 | 717,045 (1%) | 0% | 19.4 | 59,915 | Common stock |
| Jack E. Jerrett | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 8,755 | 52,107 (0%) | 0% | 0 | Common stock | |
| Jack E. Jerrett | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.64 per share. | 01 Feb 2018 | 5,867 | 43,352 (0%) | 0% | 21.6 | 126,991 | Common stock |
| Jack E. Jerrett | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 01 Feb 2018 | 1,839 | 50,268 (0%) | 0% | 21 | 38,619 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 01 Feb 2018 | 228 | 166,402 (0%) | 0% | 21 | 4,788 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 18,371 | 166,630 (0%) | 0% | 0 | Common stock | |
| Ronald H. Spair | Director, COO & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.64 per share. | 01 Feb 2018 | 980 | 148,259 (0%) | 0% | 21.6 | 21,212 | Common stock |
| Mark L. Kuna | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 01 Feb 2018 | 1,306 | 49,213 (0%) | 0% | 21 | 27,426 | Common stock |
| Mark L. Kuna | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 6,864 | 50,519 (0%) | 0% | 0 | Common stock | |
| Mark L. Kuna | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.64 per share. | 01 Feb 2018 | 4,836 | 43,655 (0%) | 0% | 21.6 | 104,675 | Common stock |
| Anthony Zezzo | EVP & BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 01 Feb 2018 | 1,382 | 148,383 (0%) | 0% | 21 | 29,022 | Common stock |
| Anthony Zezzo | EVP & BU Lead - Infectious | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 9,714 | 149,765 (0%) | 0% | 0 | Common stock | |
| Anthony Zezzo | EVP & BU Lead - Infectious | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.65 per share. | 01 Feb 2018 | 5,359 | 140,051 (0%) | 0% | 21.6 | 115,996 | Common stock |
| Michael Reed | SVP R&D and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 3,593 | 31,921 (0%) | 0% | 0 | Common stock | |
| Michael Reed | SVP R&D and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.65 per share. | 01 Feb 2018 | 1,882 | 28,328 (0%) | 0% | 21.6 | 40,736 | Common stock |
| Brian Smith | EVP & BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.64 per share. | 01 Feb 2018 | 4,273 | 19,092 (0%) | 0% | 21.6 | 92,489 | Common stock |
| Brian Smith | EVP & BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 01 Feb 2018 | 1,017 | 18,075 (0%) | 0% | 21 | 21,357 | Common stock |
| Aradhana Sarin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 40,000 | 40,000 | - | - | Non-qualified stock options | |
| Ronald H. Spair | Director, COO & CFO | 16 Jan 2018 | 824 | 109,890 (0%) | 0% | 20.8 | 17,139 | Common stock | |
| Ronald H. Spair | Director, COO & CFO | 16 Jan 2018 | 824 | 149,239 (0%) | 0% | 20.8 | 17,139 | Common stock | |
| Charles W. Patrick | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2017 | 15,000 | 0 | - | - | Nonqualified stock options | |
| Charles W. Patrick | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.25 per share. | 21 Nov 2017 | 7,922 | 58,182 (0%) | 0% | 15.3 | 120,811 | Common stock |
| Charles W. Patrick | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.06 per share. | 21 Nov 2017 | 15,000 | 66,104 (0%) | 0% | 8.1 | 120,825 | Common stock |
| Mara Glickman Aspinall | None | Purchase of securities on an exchange or from another person at price $ 14.23 per share. | 07 Nov 2017 | 5,000 | 5,000 (0%) | 0% | 14.2 | 71,164 | Common stock |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 04 Oct 2017 | 22,923 | 720,135 (1%) | 0% | 23 | 527,229 | Common stock |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 29 Sep 2017 | 25,000 | 743,058 (1%) | 0% | 22.5 | 563,713 | Common stock |
| Brian Smith | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.31 per share. | 31 Aug 2017 | 9,012 | 32,477 (0%) | 0% | 9.3 | 83,857 | COMMON STOCK |
| Brian Smith | See Remarks | Sale of securities on an exchange or to another person at price $ 20.47 per share. | 31 Aug 2017 | 9,012 | 23,465 (0%) | 0% | 20.5 | 184,476 | COMMON STOCK |
| Brian Smith | See Remarks | Sale of securities on an exchange or to another person at price $ 20.40 per share. | 31 Aug 2017 | 100 | 23,365 (0%) | 0% | 20.4 | 2,040 | COMMON STOCK |
| Brian Smith | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2017 | 9,012 | 8,507 | - | - | NON-QUALIFIED STOCK OPTIONS | |
| Charles W. Patrick | None | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 30 Aug 2017 | 1,000 | 51,104 (0%) | 0% | 20.1 | 20,110 | Common Stock |
| Brian Smith | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 21.12 per share. | 22 Aug 2017 | 1,075 | 23,465 (0%) | 0% | 21.1 | 22,704 | COMMON STOCK |
| Brian Smith | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 21.08 per share. | 22 Aug 2017 | 2,000 | 24,540 (0%) | 0% | 21.1 | 42,160 | COMMON STOCK |
| Jack E. Jerrett | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2017 | 34,683 | 0 | - | - | Nonqualified stock options | |
| Jack E. Jerrett | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 07 Aug 2017 | 6,406 | 87,999 (0%) | 0% | 5.7 | 36,610 | Common stock |
| Jack E. Jerrett | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2017 | 22,751 | 13,650 | - | - | Nonqualified stock options | |
| Jack E. Jerrett | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 07 Aug 2017 | 9,623 | 49,219 (0%) | 0% | 21.0 | 202,366 | Common stock |
| Jack E. Jerrett | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 20.73 per share. | 07 Aug 2017 | 63,840 | 58,842 (0%) | 0% | 20.7 | 1,323,282 | Common stock |
| Jack E. Jerrett | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.29 per share. | 07 Aug 2017 | 34,683 | 122,682 (0%) | 0% | 11.3 | 391,744 | Common stock |
| Jack E. Jerrett | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2017 | 6,406 | 6,407 | - | - | Nonqualified stock options | |
| Jack E. Jerrett | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.30 per share. | 07 Aug 2017 | 22,751 | 81,593 (0%) | 0% | 9.3 | 211,698 | Common stock |
| Anthony Zezzo | EVP - Infectious Diseases | Sale of securities on an exchange or to another person at price $ 21.26 per share. | 07 Aug 2017 | 72,916 | 145,410 (0%) | 0% | 21.3 | 1,550,296 | Common stock |
| Anthony Zezzo | EVP - Infectious Diseases | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 07 Aug 2017 | 72,916 | 218,326 (0%) | 0% | 5.7 | 416,708 | Common stock |
| Anthony Zezzo | EVP - Infectious Diseases | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2017 | 72,916 | 10,427 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Sale of securities on an exchange or to another person at price $ 21.29 per share. | 04 Aug 2017 | 176,197 | 109,066 (0%) | 0% | 21.3 | 3,751,675 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.29 per share. | 04 Aug 2017 | 75,207 | 184,273 (0%) | 0% | 11.3 | 849,463 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.04 per share. | 04 Aug 2017 | 99,540 | 208,606 (0%) | 0% | 7.0 | 701,259 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 50,000 | 0 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 75,207 | 0 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 72,775 | 16,075 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 99,540 | 0 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 04 Aug 2017 | 333,915 | 109,066 (0%) | 0% | 20.3 | 6,785,754 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.63 per share. | 04 Aug 2017 | 116,100 | 324,706 (0%) | 0% | 6.6 | 769,163 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.06 per share. | 04 Aug 2017 | 45,500 | 370,206 (0%) | 0% | 8.1 | 366,503 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 04 Aug 2017 | 72,775 | 442,981 (0%) | 0% | 5.7 | 415,902 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. | 04 Aug 2017 | 50,000 | 234,273 (0%) | 0% | 11.3 | 564,750 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.31 per share. | 04 Aug 2017 | 50,990 | 285,263 (0%) | 0% | 9.3 | 474,462 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 45,500 | 0 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 116,100 | 0 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 50,990 | 30,594 | - | - | Nonqualified stock options | |
| Mark L. Kuna | SVP & Controller | Sale of securities on an exchange or to another person at price $ 21.32 per share. | 04 Aug 2017 | 15,000 | 48,491 (0%) | 0% | 21.3 | 319,800 | Common stock |
| Mark L. Kuna | SVP & Controller | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 04 Aug 2017 | 46,959 | 63,491 (0%) | 0% | 20.2 | 949,567 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. | 04 Aug 2017 | 27,400 | 110,450 (0%) | 0% | 11.3 | 309,483 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 04 Aug 2017 | 3,397 | 66,888 (0%) | 0% | 5.7 | 19,414 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.30 per share. | 04 Aug 2017 | 16,162 | 83,050 (0%) | 0% | 9.3 | 150,387 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 3,397 | 5,095 | - | - | Nonqualified stock options | |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 16,162 | 9,697 | - | - | Nonqualified stock options | |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2017 | 27,400 | 0 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.29 per share. | 27 Jun 2017 | 125,954 | 894,012 (1%) | 0% | 11.3 | 1,422,650 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2017 | 125,954 | 0 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2017 | 75,000 | 0 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2017 | 89,541 | 82,378 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.28 per share. | 27 Jun 2017 | 89,541 | 768,058 (1%) | 0% | 16.3 | 1,457,817 | Common stock |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.67 per share. | 27 Jun 2017 | 75,000 | 857,599 (1%) | 0% | 16.7 | 1,250,475 | Common stock |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 27 Jun 2017 | 125,954 | 932,599 (1%) | 0% | 17.1 | 2,157,970 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.30 per share. | 27 Jun 2017 | 89,541 | 1,058,553 (1%) | 0% | 9.3 | 833,179 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.30 per share. | 27 Jun 2017 | 75,000 | 969,012 (1%) | 0% | 11.3 | 847,125 | Common stock |
| Mara Glickman Aspinall | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2017 | 40,000 | 40,000 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2017 | 10,251 | 0 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 31 May 2017 | 50,000 | 109,066 (0%) | 0% | 15.1 | 752,890 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 31 May 2017 | 39,749 | 159,066 (0%) | 0% | 5.7 | 227,162 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.19 per share. | 31 May 2017 | 10,251 | 119,317 (0%) | 0% | 5.2 | 53,203 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2017 | 39,749 | 64,737 | - | - | Nonqualified stock options | |
| Charles W. Patrick | None | Sale of securities on an exchange or to another person at price $ 15.15 per share. | 30 May 2017 | 6,666 | 52,104 (0%) | 0% | 15.2 | 100,990 | Common stock |
| Ronny B. Lancaster | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.06 per share. | 25 May 2017 | 15,000 | 21,295 (0%) | 0% | 8.1 | 120,825 | Common stock |
| Ronny B. Lancaster | None | Sale of securities on an exchange or to another person at price $ 14.73 per share. | 25 May 2017 | 74,684 | 6,295 (0%) | 0% | 14.7 | 1,100,394 | Common stock |
| Ronny B. Lancaster | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2017 | 15,000 | 0 | - | - | Nonqualified stock options | |
| Ronny B. Lancaster | None | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 25 May 2017 | 15,000 | 6,295 (0%) | 0% | 15.1 | 225,975 | Common stock |
| Eamonn P. Hobbs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2017 | 6,295 | 14,711 (0%) | 0% | 0 | Common stock | |
| Eamonn P. Hobbs | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 15 May 2017 | 3,284 | 8,416 (0%) | 0% | 15.1 | 49,679 | Common stock |
| Ronny B. Lancaster | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2017 | 6,295 | 80,979 (0%) | 0% | 0 | Common stock | |
| Ronny B. Lancaster | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 15 May 2017 | 3,919 | 74,684 (0%) | 0% | 15.1 | 59,285 | Common stock |
| Charles W. Patrick | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 15 May 2017 | 4,121 | 52,475 (0%) | 0% | 15.1 | 62,340 | Common stock |
| Charles W. Patrick | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2017 | 6,295 | 58,770 (0%) | 0% | 0 | Common stock | |
| Michael Celano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2017 | 6,295 | 41,128 (0%) | 0% | 0 | Common stock | |
| Michael Celano | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 15 May 2017 | 3,284 | 34,833 (0%) | 0% | 15.1 | 49,679 | Common stock |
| Roger L. Pringle | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 15 May 2017 | 3,861 | 72,591 (0%) | 0% | 15.1 | 58,407 | Common stock |
| Stephen S. Tang | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 15 May 2017 | 3,284 | 28,464 (0%) | 0% | 15.1 | 49,679 | Common stock |
| Stephen S. Tang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2017 | 7,952 | 36,416 (0%) | 0% | 0 | Common stock | |
| Anthony Zezzo | EVP, Marketing and Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.94 per share. | 10 May 2017 | 115,000 | 260,410 (0%) | 0% | 5.9 | 682,525 | Common stock |
| Anthony Zezzo | EVP, Marketing and Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2017 | 115,000 | 0 | - | - | Nonqualified stock options | |
| Anthony Zezzo | EVP, Marketing and Sales | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 10 May 2017 | 115,000 | 145,410 (0%) | 0% | 14.7 | 1,690,845 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2017 | 195,833 | 0 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 09 May 2017 | 209,800 | 768,058 (1%) | 0% | 15.0 | 3,149,098 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 09 May 2017 | 195,833 | 977,858 (1%) | 0% | 5.7 | 1,119,166 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.05 per share. | 09 May 2017 | 13,967 | 782,025 (1%) | 0% | 7.0 | 98,398 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2017 | 13,967 | 0 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.04 per share. | 05 May 2017 | 167,916 | 935,974 (1%) | 0% | 7.0 | 1,182,968 | Common stock |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 05 May 2017 | 79,738 | 768,058 (1%) | 0% | 15.1 | 1,203,246 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.62 per share. | 05 May 2017 | 79,738 | 847,796 (1%) | 0% | 6.6 | 528,264 | Common stock |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 05 May 2017 | 113,562 | 768,058 (1%) | 0% | 15.1 | 1,710,244 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.62 per share. | 05 May 2017 | 113,562 | 881,620 (1%) | 0% | 6.6 | 752,348 | Common stock |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 167,916 | 13,967 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 79,738 | 0 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 113,562 | 79,738 | - | - | Nonqualified stock options | |
| Douglas A. Michels | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 05 May 2017 | 167,916 | 768,058 (1%) | 0% | 15.1 | 2,533,852 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 6,500 | 10,251 | - | - | Nonqualified stock options | |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.19 per share. | 05 May 2017 | 6,500 | 115,566 (0%) | 0% | 5.2 | 33,735 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 05 May 2017 | 66,064 | 109,066 (0%) | 0% | 15 | 990,960 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 05 May 2017 | 6,500 | 109,066 (0%) | 0% | 15.0 | 97,695 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.19 per share. | 05 May 2017 | 66,064 | 175,130 (0%) | 0% | 5.2 | 342,872 | Common stock |
| Ronald H. Spair | Director, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 66,064 | 16,751 | - | - | Nonqualified stock options | |
| Charles W. Patrick | None | Sale of securities on an exchange or to another person at price $ 14.96 per share. | 05 May 2017 | 9,255 | 0 (0%) | 0% | 15.0 | 138,455 | Common stock |
| Charles W. Patrick | None | Sale of securities on an exchange or to another person at price $ 14.96 per share. | 05 May 2017 | 745 | 56,881 (0%) | 0% | 15.0 | 11,145 | Common stock |
| Charles W. Patrick | None | Gift of securities by or to the insider at price $ 14.96 per share. | 05 May 2017 | 285 | 56,596 (0%) | 0% | 15.0 | 4,264 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 5,302 | 0 | - | - | Nonqualified stock options | |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 29,413 | 5,302 | - | - | Nonqualified stock options | |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2017 | 1,698 | 8,492 | - | - | Nonqualified stock options | |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.05 per share. | 05 May 2017 | 29,413 | 92,904 (0%) | 0% | 7.0 | 207,215 | Common stock |
| Mark L. Kuna | SVP & Controller | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 05 May 2017 | 29,413 | 63,491 (0%) | 0% | 15.1 | 445,019 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.05 per share. | 05 May 2017 | 5,302 | 68,793 (0%) | 0% | 7.0 | 37,353 | Common stock |
| Mark L. Kuna | SVP & Controller | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 05 May 2017 | 5,302 | 63,491 (0%) | 0% | 15 | 79,530 | Common stock |
| Mark L. Kuna | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 05 May 2017 | 1,698 | 65,189 (0%) | 0% | 5.7 | 9,704 | Common stock |